Search for: "PFIZER"
Results 4281 - 4300
of 4,626
Sort by Relevance
|
Sort by Date
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid: (IPLaw360), … [read post]
7 Dec 2007, 6:00 am
The opinion does not mention Proposition 64 or the two pending California Supreme Court cases, Tobacco and Pfizer, in which the "reliance" question is expected to be addressed. [read post]
5 Dec 2007, 10:24 pm
Arborlaw will provide free incorporation or LLC formation for qualifying former employees of Pfizer who become entrepreneurs and start a new technology-based business in the Ann Arbor area. [read post]
District Court Upholds Validity of Pfizer's Accupril Patent, Rejecting Teva's Nonenablement Argument
5 Dec 2007, 8:56 pm
USA, No. 99-922 (D.N.J. 2007) Warner-Lambert (part of Pfizer) and Teva have been in patent litigation over Teva's ANDA for generic Accupril (quinapril hydrochloride) since 1999, when Warner-Lambert sued Teva for filing its ANDA with a paragraph IV certification to U.S. [read post]
3 Dec 2007, 7:51 am
Among its higher-profile lawyers: Amy Schulman, who represents Pfizer in its litigation over painkiller Celebrex, former congressmen Dick Armey and Dick Gephardt, and well-known corporate finance attorney Roger Meltzer. [read post]
27 Nov 2007, 2:04 pm
"The trade-off is whether richer patients in poorer but fast-growing countries such as India, China and Brazil should not contribute more to the overall costs of medical innovation, rather than simply paying the marginal production cost of drugs.Companies such as GlaxoSmithKline and Pfizer have been studying whether they can introduce more differential pricing within developing countries, charging less to poorer patients while preventing richer ones from getting those drugs as cheaply. [read post]
27 Nov 2007, 8:05 am
Pfizer's clinical trial data was manipulated at that time to demonstrate that the drug Celebrex did not cause ulcers after 6 months of use. [read post]
26 Nov 2007, 7:44 pm
Pfizer, Inc., 439 F.3d 1358, 1362-63 (Fed. [read post]
26 Nov 2007, 3:06 pm
FDA Staff Says, we learn that: Global revenue for Serevent and Advair rose 12 percent to $6.13 billion last year, making the medicines the second-best-selling in the world behind Pfizer Inc.'s cholesterol drug Lipitor. [read post]
21 Nov 2007, 7:41 am
The FDA is looking into possible links between Pfizer's anti-smoking drug Chantix and various mental or emotional effects. [read post]
21 Nov 2007, 6:00 am
Supreme Court Justice Breyer) issued a Daubert ruling in the Pfizer Celebrex litigation. [read post]
21 Nov 2007, 4:08 am
Patent No. 6,336,018, entitled "Electrophotographic image forming apparatus, process cartridge, and drive mount for photosensitive drum"); "[i]n patent cases, traditional rules of equity apply to requests for injunctive relief"; "[i]n considering whether to grant a preliminary injunction, a court must consider whether the patent owner has shown: (1) a reasonable likelihood of success on the merits; (2) the prospect of irreparable harm to the patent owner in the absence of… [read post]
20 Nov 2007, 9:35 am
Pfizer has won a Daubert motion in the Celebrex litigation that may significantly reduce the size of the litigation. [read post]
20 Nov 2007, 7:52 am
Responding to plaintiff's claim that "evidence of harm at 200 mg/d does not exist because Pfizer did not initiate long term randomized trials at such dose," Judge Breyer responds that "[p]laintiffs cite no case ... that suggests that they can satisfy their burden of proof based on lack of evidence; plaintiffs filed these lawsuits and plaintiffs carry the burden of proving today based on currently available scientifically valid evidence that Celebrex can cause heart… [read post]
20 Nov 2007, 6:32 am
The newswires reported this morning that Pfizer picked off a Daubert motion in its Celebrex multidistrict litigation proceeding.It did, indeed, with Judge Breyer rejecting as junk science plaintiffs' proffered expert testimony that Celebrex is capable of causing heart attacks or strokes at the 200mg/day level.Here's a link to the opinion, courtesy of Pharmalot.We may have more to say after we have a chance to think about this decision.On the other hand, we may do a couple of… [read post]
20 Nov 2007, 5:55 am
Pharmalot has the details and the order (in Word form, with metadata indicating it originated from plaintiffs' firm Lieff Cabraser) finding no Daubert-worthy evidence of causation at the most common dose of 200 mg. [read post]
19 Nov 2007, 3:07 pm
Singer -- In a November 16, 2007 press release, Pfizer Inc. announced that it will acquire Coley Pharmaceutical Group, Inc. [read post]
19 Nov 2007, 12:02 pm
She was behind Pfizer’s win in the Celebrex litigation yesterday. [read post]
19 Nov 2007, 8:01 am
That is the most common dosage, according to Pfizer, whose general counsel Allen Waxman said the company was psyched about the decision. [read post]
15 Nov 2007, 1:49 pm
Pfizer, Inc., No. 06-2627. [read post]
